Inga Reynisdottir

3PUBLICATIONS
1CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 26, 2023
High Atlastin 2-2 (ATL2-2) Expression Associates with Worse Prognosis in Estrogen-Receptor-Positive Breast Cancer.

Inga Reynisdottir, Adalgeir Arason, Edda S Freysteinsdottir

|Nov 19, 2021
Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways.

Arsalan Amirfallah, Hildur Knutsdottir, Adalgeir Arason

Pageof 1

Frequent Collaborators